01 Latch and pumping come before a 10 mg experiment
Low supply has mechanical and frequency causes more often than a missing European tablet. A lactation clinic, weighted feeds, and a pump plan are the first how-to. Domperidone, where someone still writes it, is an off-label add-on with a QT pretest from the QT margin.
This site will not time 10 mg around a pump session. The leaf will not invent a US dollar. Quality of an internet pack is unknown.
InfantRisk and LactMed discuss small average volume changes and a residual cardiac risk. They do not hand Bordeaux a license.
02 How a lactation clinic visit should run before anyone names Motilium
Latch, weighted feeds, pump frequency, and a clinic that can see you. Those are the first how-to. Domperidone, where someone still writes it, is an off-label add-on with a QT pretest.
No licensed milk-supply indication on the restricted EU label. The FDA has not approved the drug and has warned US breastfeeding people against import and compounding for supply.
This site will not time 10 mg around a pump. It will not invent ounces. It will not invent a US dollar.
Build the QT list first. Family long QT matters for the person swallowing the tablet. The QT margin stays in the bag.
The leaf has the 10 mg lock and the no-US-cash line.
03 Ten milligrams three times is the study-shaped ceiling, not a ladder
Most published supply studies used 10 mg TID for days (often 4-10). Two small studies found 20 mg TID did not add a statistically meaningful extra volume and non-responders to 10 mg did not become responders at 20. Daily totals above 30 mg track with more arrhythmia concern in observational work.
Weeks-to-months of 10 mg TID for supply is a longer exposure than the EU nausea "shortest time" speech. That mismatch is why regulators narrowed the license and why the FDA warning exists.
Stop and seek care for palpitations, syncope, or seizures. Do not raise the tablet because the scale did not move.
| Claim | What the files actually say |
|---|---|
| Licensed for lactation | No - not on the restricted EU indication; not FDA-approved |
| 10 mg TID for days | Common study pattern; still off-label for supply |
| 20 mg TID if 10 mg fails | Small studies: no reliable rescue |
| US compounding / import | FDA has warned against it for milk supply |
04 Why 20 mg three times is not a rescue when 10 mg "failed"
Most published supply studies used 10 mg TID for days. Two small studies found 20 mg TID did not add a reliable extra volume and non-responders to 10 mg did not become responders at 20. Daily totals above 30 mg track with more arrhythmia concern.
A group chat that says 20 mg until 4 ounces is a higher exposure and not an ECG.
Weeks-to-months of 10 mg TID is already longer than the EU nausea shortest-time speech. That mismatch is why regulators narrowed the license.
Stop for palpitations, syncope, or seizures. Do not raise the tablet because the scale did not move.
Infant milk levels are low in published samples. Low is not zero. The parent's QT is still the limiter.
05 How to stop a supply course that should have had a stop date
If someone wrote 10 mg TID, they should have written when to stop. Ask. Do not extend because a quiet day felt good.
Do not taper like a steroid unless they said to. Do not donate leftover 10 mg to a friend in the same parenting group.
If supply falls after the stop, go back to the mechanical plan, not to 20 mg.
If you never had a cardiac check, stopping and telling the next clinician is still useful. The list remains.
Elise put the claim under the safety line. Mail us if we implied a licensed lactation indication.
06 How a supply visit should start before anyone names 10 mg
Latch, weighted feeds, pump frequency, and a lactation clinic. Those are the first how-to. Domperidone, where someone still writes it, is an off-label add-on with a QT pretest.
No licensed milk-supply indication on the restricted EU label. The FDA has not approved the drug and has warned US breastfeeding people against import and compounding for supply.
This site will not time 10 mg around a pump. It will not invent ounces. It will not invent a US dollar.
Build the QT list first. Family long QT matters for the person swallowing the tablet.
07 How to stop a supply course that should have had a stop date
If someone wrote 10 mg TID, they should have written when to stop. Ask. Do not extend because a quiet day felt good.
Do not taper like a steroid unless they said to. Do not donate leftover 10 mg to a friend in the same parenting group.
If supply falls after the stop, go back to the mechanical plan, not to 20 mg.
If you never had a cardiac check, stopping and telling the next clinician is still useful. The list remains.
Elise put the claim under the safety line. Mail us if we implied a licensed lactation indication.
08 Why 20 mg three times is not a rescue
Most published supply studies used 10 mg TID for days. Two small studies found 20 mg TID did not add a reliable extra volume and non-responders to 10 mg did not become responders at 20. Daily totals above 30 mg track with more arrhythmia concern.
A group chat that says 20 mg until 4 ounces is a higher exposure and not an ECG.
Weeks-to-months of 10 mg TID is already longer than the EU nausea shortest-time speech. That mismatch is why regulators narrowed the license.
Stop for palpitations, syncope, or seizures. Do not raise the tablet because the scale did not move.
Infant milk levels are low in published samples. Low is not zero. The parent's QT is still the limiter.
09 The infant is in the story even when the tablet is "peripheral"
Domperidone into milk is low in published samples, which is why people call it safer than metoclopramide for the parent's CNS. Low is not zero, and the parent's QT is still the limiter. Do not add other QT drugs "for mastitis nausea" without a list.
If supply is the only goal and the cardiac list is not empty, the tablet is the wrong tool. That sentence is the whole point of this margin.
10 Claim filed under safety, not under a pump app
Reviewed 21 August 2026, Elise Moreau, Bordeaux. Mail [email protected] about wording, not about ounces.
Start with latch, weighted feeds, and pump frequency. Domperidone, where someone still writes it, is an off-label add-on with a QT pretest. There is no licensed milk-supply indication on the restricted EU label. The FDA has not approved the INN and has warned US parents against import and compounding for supply.
Most published supply work used 10 mg three times daily for days. Twenty milligrams three times did not reliably rescue non-responders in small studies and raises daily totals above 30 mg. Do not chase ounces with a higher tablet. Infant levels are low in samples. Low is not zero.
Ask for a stop date. Do not donate leftover 10 mg. The leaf and the QT margin stay in the bag. Mail [email protected] if we implied a licensed lactation indication.
One ounce per feed is not a reason this inbox will promise a double. Published averages are small and individual. A compounding jar is not safer than an import blister in the FDA warning history. Start with a lactation clinic. Sleep while a partner pumps is not a Motilium indication on the restricted label.
Do not donate leftover 10 mg to a parenting group. If supply falls after a written stop, go back to the mechanical plan, not to 20 mg. If you never had a cardiac check, stopping and telling the next clinician is still useful. The QT list remains. Infant milk levels are low in samples. Low is not zero.
Weeks-to-months of 10 mg TID is already longer than the EU nausea shortest-time speech. That mismatch is why regulators narrowed the license. Stop for palpitations, syncope, or seizures. Do not raise the tablet because a scale did not move. A group chat that says 20 mg until 4 ounces is a higher exposure and not an ECG.
Build the QT list before anyone names 10 mg for supply. Family long QT matters for the person swallowing the tablet. This site will not time 10 mg around a pump and will not invent ounces. Official US pharmacy links, if they appear on a fill strip, are literacy. They are not Motilium stock.
Virena does not sell Motilium. Elise put the milk-supply claim under the QT safety line on this leaf. No ounce target.